Friday, February 6, 2026

5 MINUTES TO IMPACT: Kim’s Nuclear Cruise Missile Exposes US-Korea Defense Gap—A Strike Is Now INEVITABLE

North Korea tested a strategic cruise missile over the Yellow Sea, aiming to enhance its vertical launch capabilities against South Korea.

No More Lab Rats? FDA Shift Spurs AI Boom in Drug Development

AI is transforming drug discovery in pharma, especially after the FDA's shift away from animal testing, enhancing efficiency.

Bae’s Back: Pirates Prospect Powers Through After Injury!

Pittsburgh Pirates' Bae Ji Hwan has shaken...

Tag: SJN314

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Top News

- Our Sponsors Ad -

Follow us